Lecture 3- Prion Diseases Flashcards
prion diseases
transmissible spongiform encephalopathies
3 pathogenic features of prion diseases
- degeneration and death of neurons- spongy form, vacuolation, associated with apoptosis, activated caspases
- accumulation of abnormal form of PrP (misfolded protein PrP*Sc)
- astrocytosis- hypertrophy and hyperplasia of astrocytes in gray matter
GFAP
detects protein present in normal astrocytes- more staining in affected brain
mad cow disease
bovine spongiform encephalopathy
how do exotic animals get prion disease?
feed mad cow meat to cheetahs, antelopes etc- disease easily transmissible
sporadic Prion disease
85%- majority of forms in australia
familial prion disease
15%- mutation of prion protein predisposes you to misfolding of protein
3 familial prion diseases
GSS- cerebellar ataxia
CJD- rapidly progressive dementia
FFI- intractable insomnia
acquired prion disease
iatrogenic (medical intervention) or zoonotic (eating mad cow)
epidemiology of prion disease
rare; 1-2 cases per million per year
main characteristic of prion disease
transmissible in the absence of conventional infectious agent e.g. zoo animals eating mad cow, urine/faeces
proteinaceous infectious particle
resistant to inactivation by most procedures that modify nuclei acids i.e. prions dont require nuclei acids for infectivity
what was the infectious agent initially thought to be?
exogenous agent, proteases resistant which copurifies with infectivity
what was infectious agent later shown to be?
post translational modification of a normal cellular protein PrP (since mRNA present in infected and un infected)
PrP*C
normal cellular form, protease sensitive (disappears under proteinase K), soluble, alpha helix, many tissues (highest in brain), required for infection
PrP*Sc
misfolded protein, protease resistant, insoluble, beta sheet, disease specific, infectious
- can go back and recruit more normal cellular form
protein only hypothesis
PrP from normal cellular form gets mutation–>disease associated form
- misfolded protein can go back and recruit more normal cellular form
5 evidence for PrP*Sc- major component of disease/infectivity
- physical association with clinical disease
- co-purifies with infectivity
- concentration of PrP*Sc proportional with infectivity
- biophysical state correlates with infectivity profile (protease resistance, solubility)
- mutations in PRNP (gene that encodes prion protein) linked to disease
gene dosage effect for PrP
increasing amount of PrP; incubation period and clinical progression is shorter
in the presence of PrP*Sc, where is pathology observed?
only observed in tissue expressing PrP*C
evidence that pathology can be reversed
- despite presence of PrPC, pathology reversed when PrPSc propagation stopped (reversed early spongiform change)- transgenic mice–>PrP 12 weeks then off
- RNAi targeting PrP*C epxression
- both prolong survival time, reduce pathology, improve cognitive and behavioural deficits
why was there no clinical disease in GPI/Tg mice despite accumulation of misfolded PrP*Sc?
PrPSc propagation was not associated with membrane anchored PrPC
proving the protein-only hypothesis; propagation
- partially purified PrPSc can induce conformational change in mammalian and recombinant PrPSc
- crude brain homogenates propagate prions
- cell-free conversion assay
cell-free conversion assay
PrPC converted into protease resistant protein in presence of excess PrPSc
- proved template directed misfolding
proving protein only hypothesis; infectivity
- infectivity spontaenously generated from partially purified mammalian and recombinant PrP*Sc
- RNA stimulated misfolding of mammalian PrPC when not seeded with PrPSc
recombinant PrP forms into?
amyloid fibrils
prion strains characterised by (4)
clinical phenotype e.g. weight loss, weight gain
location of damage in brain
incubation period
conformation of PrP*Sc
strains of hamster scrapie
HY- hyper strain
DY- drowsy strain
HY-hyper strain
short incubation, brain stem and cerebellar cortex, hyperactivity
DY-drowsy strain
long incubation, pyramidal layer adjacent to hippocampus, lethargy
PrP*Sc from HY and DY strains
different electrophoretic mobility following PK digestion, different FTIR spectroscopy profile
- suggests different conformatins of PrP*Sc associated with strain variation
- same with CJD strains
prion strains overall
not due to nucleic acid variation
can be reproduced in cell-free assays of prion propagation